Senior insider sale
President and COO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$206.0K
13.29K shares
What this filing means
METZGER MICHAEL A plans to sell 13.29K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $206.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/10/2025ACC: 0001959173-25-000835
Officer· President and COO
Since Feb 2019
13.29K
Shares to sell
$206.0K
Approx. market value
13.29K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/7/2025
13.29KTotal acquired13.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/7/2025 | Restricted Stock Vesting Compensation | 13.29K | — |
| Total | 13.29K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.29K
Market value
$206.0K
2/10/2025
Total
Units
13.29K
Value
$206.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/10/2025 | 13.29K | $206.0K | NASDAQ | Planned |
| Total | 13.29K | $206.0K | ||